Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Nathanson

Showing results (231-240 of 528) with videos related to

Pageof 53
Sort By:
JCO Precision Oncology|February 24, 2022
<i>PTEN</i> Loss and <i>BRCA1</i> Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian CancerAdam A Kraya, Kara N Maxwell, Monika A Eiva, et al.
Pigment Cell Research|July 11, 2006
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signatureKeith S Hoek, Natalie C Schlegel, Patricia Brafford, et al.
NPJ Precision Oncology|January 31, 2026
Metastatic progression of pheochromocytoma and paraganglioma occurs via parallel evolutionAndrew M Pregnall, Bradley Wubbenhorst, Kurt D'Andrea, et al.
Oncogene|September 17, 2008
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutationsK S M Smalley, M Xiao, J Villanueva, et al.
Cancer Immunology Research|September 26, 2014
Immune activation and a 9-year ongoing complete remission following CD40 antibody therapy and metastasectomy in a patient with metastatic melanomaDavid L Bajor, Xiaowei Xu, Drew A Torigian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinicA M Martin, M A Blackwood, D Antin-Ozerkis, et al.
Scientific Reports|February 23, 2019
Cholinergic Stimulation by Pyridostigmine Bromide Before Myocardial Infarction Prevent Cardiac and Autonomic DysfunctionC A Barboza, A R Fukushima, N Carrozzi, et al.
Biotechniques|July 4, 2019
Hi-Plex2: a simple and robust approach to targeted sequencing-based genetic screeningFleur Hammet, Khalid Mahmood, Thomas R Green, et al.
Plos One|August 13, 2013
Expression of drug targets in patients treated with sorafenib, carboplatin and paclitaxelLucia B Jilaveanu, Fengmin Zhao, Christopher R Zito, et al.
Gastroenterology|September 24, 2018
Earlier Colorectal Cancer Screening May Be Necessary In Patients With Li-Fraumeni SyndromeSuzanne P MacFarland, Kristin Zelley, Jessica M Long, et al.
Pageof 53

Showing results (231-240 of 528) with videos related to

Sort By:
Pageof 53
JCO Precision Oncology|February 24, 2022
<i>PTEN</i> Loss and <i>BRCA1</i> Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian CancerAdam A Kraya, Kara N Maxwell, Monika A Eiva, et al.
Pigment Cell Research|July 11, 2006
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signatureKeith S Hoek, Natalie C Schlegel, Patricia Brafford, et al.
NPJ Precision Oncology|January 31, 2026
Metastatic progression of pheochromocytoma and paraganglioma occurs via parallel evolutionAndrew M Pregnall, Bradley Wubbenhorst, Kurt D'Andrea, et al.
Oncogene|September 17, 2008
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutationsK S M Smalley, M Xiao, J Villanueva, et al.
Cancer Immunology Research|September 26, 2014
Immune activation and a 9-year ongoing complete remission following CD40 antibody therapy and metastasectomy in a patient with metastatic melanomaDavid L Bajor, Xiaowei Xu, Drew A Torigian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinicA M Martin, M A Blackwood, D Antin-Ozerkis, et al.
Scientific Reports|February 23, 2019
Cholinergic Stimulation by Pyridostigmine Bromide Before Myocardial Infarction Prevent Cardiac and Autonomic DysfunctionC A Barboza, A R Fukushima, N Carrozzi, et al.
Biotechniques|July 4, 2019
Hi-Plex2: a simple and robust approach to targeted sequencing-based genetic screeningFleur Hammet, Khalid Mahmood, Thomas R Green, et al.
Plos One|August 13, 2013
Expression of drug targets in patients treated with sorafenib, carboplatin and paclitaxelLucia B Jilaveanu, Fengmin Zhao, Christopher R Zito, et al.
Gastroenterology|September 24, 2018
Earlier Colorectal Cancer Screening May Be Necessary In Patients With Li-Fraumeni SyndromeSuzanne P MacFarland, Kristin Zelley, Jessica M Long, et al.
Pageof 53